Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial-Reference-Cited by-同舟云学术

Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial

Published:1990 Issue:4 Volume:19 Page:425-434
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Becker Robert E.,Colliver Jerry,Elble Rodger,Feldman Eleanor,Giacobini Ezio,Kumar Vinod,Markwell Stephen,Morieatry Pamela,Parks Randolph,Schillcutt Samuel D.,Unni Latha,Vicari Sandra,Womack Cindy,Zec Ronald F.

Publisher

Wiley

Subject

Drug Discovery

Reference27 articles.

1. Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects

2. “Mini-mental state”

3. : ?ECDEU Assessment Manual for Psychopharmacology.? Rockville, MD: U.S. Department of Health, Education and Welfare, 1976.

4. MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introduction;Alzheimer Disease;2020-07-24

2. Resurrecting Clinical Pharmacology As a Context for Alzheimer Disease Drug Development;Current Alzheimer Research;2009-02-01

3. Effects of trichlorfon and sodium dodecyl sulphate on antioxidant defense system and acetylcholinesterase of Tilapia nilotica in vitro;Pesticide Biochemistry and Physiology;2008-11

4. Alzheimers Disease Drug Development in 2008 and Beyond: Problems and Opportunities;Current Alzheimer Research;2008-08-01

5. Metrifonate: A Cholinesterase Inhibitor for Alzheimer's Disease Therapy;CNS Drug Reviews;2006-06-07